BMC Urology· 2026Q2
Patient-reported outcomes after revision to the Rigicon® Infla10 inflatable penile prosthesis: a multicentre retrospective registry cohort with a cross-sectional telephone survey
- 0citations
- Q2SCImago
- 2026year
Short summary
Revision to the Rigicon® Infla10 IPP resulted in significantly higher patient satisfaction (94.4% vs. 71.8% recalled) and improved rigidity (90.3% vs. 61.3%) compared to prior devices.
AI-generated from the title and abstract; the full text is not read.
Key points
- Revision to the Rigicon® Infla10 IPP led to a mean satisfaction increase of 22.6 percentage points compared to prior devices.
- Good or excellent rigidity was reported by 90.3% of participants with the Infla10, versus 61.3% with their previous IPP.
- Overall satisfaction with the Infla10 was high at 94.4% in this cohort of 62 men from 11 countries.
- The study identified 21 participants who experienced improved rigidity after switching to the Infla10.
AI-generated from the title and abstract; the full text is not read.
Abstract
Revision of an inflatable penile prosthesis (IPP) is technically more demanding than primary implantation and usually requires complete IPP removal and replacement. In selected revision cases, patient expectations or surgeon preference may lead to substitution with an IPP from a different manufacturer. This study evaluated patient-reported outcomes in men undergoing revision from an IPP from another manufacturer to the Rigicon ® Infla10 IPP. This retrospective registry cohort included a cross-sectional postoperative telephone survey. Men who underwent complete explantation of an IPP made by another manufacturer, followed by implantation of the Rigicon ® Infla10, were identified in the Rigicon Post-Implant Follow-up Registry. During a single postoperative interview, participants rated their current Infla10 and retrospectively recalled their prior IPP. Overall satisfaction and perceived rigidity for both devices, ease of inflation and deflation, preference, and willingness to recommend the Infla10 were assessed. Among 62 participants from 11 countries, median postrevision follow-up was 20.8 months (IQR, 18.4–21.7). Mean (SD) recalled satisfaction with the prior IPP was 71.8% (6.5), compared with 94.4% (3.7) for the current Infla10. The mean within-participant difference was 22.6% points (BCa paired-bootstrap 95% CI, 21.0–25.3; Wilcoxon p < 0.001). Good or excellent rigidity was recalled for the prior IPP by 38/62 participants (61.3%) and reported for the current Infla10 by 56/62 (90.3%); 21 improved and 3 worsened (exact McNemar p = 0.0003). In this registry-based series, participants reported high current satisfaction and favorable current rigidity after revision to the Infla10. The uncontrolled design, retrospective recall of the prior IPP, unvalidated questionnaire, and non-participation of 37/99 eligible patients limit interpretation. These findings are hypothesis-generating and require validation using prospective, validated assessments and an active comparator.
The authors' abstract, as published at the source. BMC Urology, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Psychiatry and Mental health
Psychiatry and Mental healthMedicine